Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Anticancer Drugs 2021
| Anticancer Drugs 2021 |
| Autore | Meegan Mary J |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (594 p.) |
| Soggetto topico |
Chemistry
Research & information: general |
| Soggetto non controllato |
1,2,3-triazole
1,3,4-oxadiazole 3-amino-4'-guanidino 3,4'-bis-guanidino 5-fluoruracil 7-deaza-4'-thioadenosine derivatives acetamide adamantane ADC (antibody-drug conjugate) age alkylated anticancer anticancer activity anticancer agents apoptosis apoptosis induction aromatase inhibitor Bcl-2 inhibitors benzenesulfonamides benzimidazole BRAF breast cancer cancer cancer cell viability cancer vaccine CAR (chimeric antigen receptor) cardiotoxicity carvedilol cell cycle analysis chalcone chalcones colony formation combretastatin A-4 concentration-guided dosing covalent binding CovDock cumulative dose cyclophosphamide cytotoxic activity cytotoxic agents cytotoxicity designed multiple ligand diphenyl ether DNA fragmentation docking doxazosin drug efflux dual inhibitors dual-targeting molecule EGFR ELISA enantioselective synthesis entrectinib exportin-1 gastric adenocarcinoma generic product H1299 HDAC inhibitors HER2 heterocyclic compound histopathology HL-60 HT-29 cells hybrid compounds hybrid molecule hydrazide derivatives imidazoles Imiquimod immunotherapy in vitro in vivo indazole Indole-based analogues inflammation interleukin-6 intramolecular hydrogen bond isolation kidney larotrectinib letrozole MD simulations MDA-MB-231 cells mechanism prediction miR-21 mitoxantrone model informed dosing MTT cytotoxic assay MUC1 MUC16 mucin multi-kinase inhibitor multidrug resistance n/a NaMSA nitrogen scaffolds NTRK nucleoside oxidative stress patent review pemetrexed phenstatin phenyl pyridyl ether physiologically based pharmacokinetics protein kinase inhibitors resin acid solid/lipid nanoparticles sorafenib STAT inhibitors synthesis TDP1 testis thieno[2,3-d][1,2,3]triazine thiourea thymidylate synthase tissue-agnostic Toll-Like Receptor toxicity Trk Trk fusion trypan blue assay tryptophanol tubulin polymerisation inhibitor tumor spheroids tyrosil-DNA-phosphodiesterase 1 urinary bladder USFDA xanthone |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576874303321 |
Meegan Mary J
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Creatine Supplementation for Health and Clinical Diseases
| Creatine Supplementation for Health and Clinical Diseases |
| Autore | Kreider Richard B |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (562 p.) |
| Soggetto topico |
Biology, life sciences
Food & society Research & information: general |
| Soggetto non controllato |
activated protein kinase (AMPK)
adaptive immunity adenosine 5'-monopnophosphate-activated protein kinase Adenosine mono-phosphate (AMP) adipose tissue amino acids amyotrophic lateral sclerosis anemia anthracycline anthracyclines anti-inflammatory anticancer antioxidant athletes athletic performance atrophy bioinformatics BMI-for-age brain injury cachexia cancer immunotherapy cardiac infarction cardiac signaling cardiac toxicity cardiopulmonary disease cardiotoxicity cardiovascular disease cell survival cellular allostasis cellular metabolism children chronic fatigue chronic fatigue syndrome clinical trial cognition cognitive impairment concussion creatine creatine kinase creatine kinase (CK) creatine perfusion creatine supplementation creatine synthesis deficiencies creatine transporter creatine transporter (CrT) Crohn's disease cytotoxic T cells depression development diabetes dietary ingredients dietary supplement dietary supplements doxorubicin dynamic biosensor energy metabolism ergogenic aid ergogenic aids exercise exercise performance female fertility frailty GAA glucose transporter (GLUT) glycemic control growth heart heart failure height hemodialysis hormones hyperhomocysteinemia hypertrophy hypoxia immobilization immunity inflammation inflammatory bowel diseases (IBD) innate immunity intestinal epithelial cell protection intestinal tissue protection intradialytic creatine supplementation ischemia liver kinase B1 (LKB1) long COVID macrophage polarization MAP kinase signaling system MCDA menopause menstrual cycle metabolic regulator methylation mitochondria mitochondrial cytopathy mitochondrial permeability transition pore (mPTP) mitochondriopathia mood muscle muscle atrophy muscle damage muscle fatigue muscle strength muscle weakness muscular adaptation muscular dystrophy muscular power myocardial infarction neurodegenerative diseases neuromodulation newborn noncommunicable disease nutritional supplements organ transplantation osteoporosis osteosarcopenia oxidative stress Parkinson's Disease performance phosphagens phosphocreatine phosphocreatine (PCr) phosphorylcreatine physiological adaptation pleiotropic effects of creatine (Cr) supplementation post-viral fatigue syndrome pregnancy protein energy wasting reactive oxygen species (ROS) recovery rehabilitation resistance exercise resistance training sarcopenia signal transduction skeletal muscle sodium-chloride-dependent neurotransmitter symporters soy spinal cord injury sports nutrition stature-for-age strength stroke supplementation supplements systems biology T cell antitumor immunity thermogenesis toll-like receptors toxicity training traumatic brain injury treatment type 2 diabetes mellitus ulcerative colitis vascular health vascular pathology vegetarian/vegan diet weightlifting youth |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566476003321 |
|
Kreider Richard B
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-oncology: From Bench to Bedside
| Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-oncology: From Bench to Bedside |
| Autore | Nebigil Canan G |
| Pubbl/distr/stampa | Frontiers Media SA, 2020 |
| Descrizione fisica | 1 online resource (127 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
antracyclines
biomarkers cardiooncology cardiotoxicity epigenetics (methylation/demethylation) GPCR (G protein coupled receptors) HDLP HPSC-cardiomyocytes |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-oncology |
| Record Nr. | UNINA-9910557230403321 |
|
Nebigil Canan G
|
||
| Frontiers Media SA, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Immunotherapy, Tumor Microenvironment and Survival Signaling
| Immunotherapy, Tumor Microenvironment and Survival Signaling |
| Autore | Golubovskaya Vita |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (376 p.) |
| Soggetto topico |
Clinical and internal medicine
Medicine and Nursing |
| Soggetto non controllato |
angiogenesis
antigen loss Autophagy BCMA breast cancer cancer cancer immunotherapy cancer metabolism cancer nanomedicine cancer stem cells cancer vaccines CAR macrophage CAR T cell CAR-T CAR-T cells cardiotoxicity CD11 CD18 CD19 CD37 cell therapy cell-cell contact check point inhibitors checkpoint chemotherapy chimeric antigen receptor chimeric antigen receptors clonogenicity colorectal cancer combination therapy crosstalk DCLK1 dendritic cells electroporation hypoxia immune checkpoint inhibitor immune checkpoint inhibitors immune escape immunogenic cell death immunometabolism immunomodulation immunomodulators immunotherapeutic agent immunotherapies immunotherapy lentiviral transduction lentivirus leukemia cells lung metastasis lymphoma lytic peptides macrophages melanoma microenvironment miRNA mitochondria mitochondrial transfer myeloid-derived suppressor cells n/a nanoparticles oncolytic viral therapy pathogenesis pediatric solid tumors personalized medicine programmed cell death 1 ligand 1 programmed cell death protein 1 regulatory T cells resistance risk factors solid tumors targeted therapy targeted treatment triple-negative breast cancer tuft cells tumor tumor antigen tumor antigens tumor immune evasion tumor microenvironment tumor stem cells tumor stroma tunneling nanotubes tyrosine kinase inhibitors β2 integrins |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910580205403321 |
|
Golubovskaya Vita
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ischemic Heart Disease in the Context of Different Comorbidities
| Ischemic Heart Disease in the Context of Different Comorbidities |
| Autore | Costache Irina-Iuliana |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (242 p.) |
| Soggetto topico |
Medicine
Cardiovascular medicine |
| Soggetto non controllato |
coronary artery disease
ischemic heart disease atherosclerosis genetic risk factors heritability polymorphism GWAS PRS COVID-19 myocardial ischemia electrocardiography accelerated atherosclerosis coronary spasm coronary thrombosis endothelial dysfunction cancer prevention radiotherapy chemotherapy liver cirrhosis prevalence liver transplantation treatment myocardial injury cytokines biomarkers heart failure left ventricular remodeling myocardial infarction wall stress inflammation neurohormonal activation inflammatory bowel disease ulcerative colitis Crohn's disease cardiovascular risk frailty chronic coronary syndrome elderly acute coronary syndrome carbon monoxide poisoning severity of poisoning cardiotoxicity troponin cardiac dysfunction non-alcoholic fatty liver disease liver-heart axis |
| ISBN | 3-0365-5809-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910637784603321 |
|
Costache Irina-Iuliana
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New Prognostic and Predictive Markers in Cancer Progression
| New Prognostic and Predictive Markers in Cancer Progression |
| Autore | Costantini Susan |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (294 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
acetyltransferase
AKT antigen processing machinery (APM) molecules AR biomarker biomarkers bladder cancer blood BRCA1/2 breast cancer cancer cancer immunotherapy cancer prognosis carcinogenesis cardioncology cardiotoxicity castration-resistant prostate cancer (CRPC) CD8+ T effector cells chemo-/radio resistance CSC CTCs cytokines EMT eribulin genetic syndromes genomic mutations head and neck cancer head and neck neoplasms head and neck tumors HRR HUB nodes human leukocyte antigen (HLA) hyperglycemia immune checkpoint inhibitor K-RAS oncogene laryngeal cancer lifestyle habit major histocompatibility complex (MHC) MAPK melanoma melanoma resistance to MAPK/MEK inhibitors metabolomics metastasis microRNA miRNA MSI2 mTOR musashi 2 mutations N-cadherin n/a NAA10 new metastasis nivolumab oncogene dependency oral cancer OSCC pancreatic cancer paraganglioma PDL1 pheochromocytoma PI3K PI3KCA prediction prognosis prostate cancer PTEN resistance to immune checkpoint inhibitors selenoproteins targeted therapies therapeutic resistance therapeutic target TILs TNBC transcriptomics tumor predisposition WNT |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557794803321 |
|
Costantini Susan
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Physiological and Pathological Role of ROS: Benefits and Limitations of Antioxidant Treatment
| Physiological and Pathological Role of ROS: Benefits and Limitations of Antioxidant Treatment |
| Autore | Di Meo Sergio |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (236 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
AMPK pathway
antioxidant supplementation AP-1 apoptosis artemisinin atherosclerosis c-FLIP cancer cancer therapy cardiomyocytes cardiotoxicity cardiovascular disease cavefish cell viability chromophobe RCC clear cell RCC CORM-2 CTCL D-box DNA damage endoplasmic reticulum stress endothelial dysfunction evolution exercise glutathione (GSH) metabolism H2O2 hippocampal neurons HO-1 insulin resistance light mitochondria mitochondrial membrane potential n/a NADPH oxidase neurodegenerative disorders Nrf2 oxidative stress papillary RCC peroxiredoxins PGC-1 protein aggregation proteinopathy reactive oxygen species reactive oxygen species (ROS) redox redox signaling Renal cell carcinoma (RCC) ROS ROS scavengers sarcopenia SH-SY5Y cells Spalax sphingomyelin synthase 2 trimethylamine N-oxide tumorigenesis UCPs XIAP β-catenin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Physiological and Pathological Role of ROS |
| Record Nr. | UNINA-9910557430503321 |
|
Di Meo Sergio
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||